MUD

10.1304.54%

E

EdmundK

Singtel Return Rate

Orders

Aug 20 at 03:46 AM

$Moderna(MRNA.US) +177% is validation that mRNA isn’t just for COVID. First Phase 3 cancer win with $Merck(MRK.US) opens a massive new market. And SK Hynix buying back means memory demand is real - $Sandisk(SNDK.US) and $Micron Tech(MU.US) catching that bid makes sense.

C

Captain's Watch

Featured☕️ [Task Coins Giveaway] Daily Market Talk — Moderna Soars 177% on Landmark Cancer Vaccine Win

Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...

Moderna

USMRNA

Merck

USMRK

Sandisk

USSNDK

Micron Tech

USMU

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.